Fibrinolysis with Lower Dose Urokinase in Patients with Complicated Parapneumonic Effusion

BACKGROUND: Intrapleural urokinase is one of the most widely used fibrinolytic agents in the treatment of complicated parapneumonic effusion (CPPE). However, little research has been performed on the optimal urokinase dosage. The aim of this study was to evaluate the treatment efficacy of half dose...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Seul, Lee, Heock, Lee, Dong Hyun, Kang, Bo Hyoung, Roh, Mee Sook, Son, Choohee, Kim, Sung Hyun, Lee, Hyun-Kyung, Um, Soo-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Tuberculosis and Respiratory Diseases 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010421/
https://www.ncbi.nlm.nih.gov/pubmed/33327051
http://dx.doi.org/10.4046/trd.2020.0018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010421/
https://www.ncbi.nlm.nih.gov/pubmed/33327051
http://dx.doi.org/10.4046/trd.2020.0018

Ejemplares similares